New Brief: Counterfeit Drugs Harm Patients, Economy, Innovation
PRI Center for Medical Economics and Innovation | Henry Miller, M.S., M.D. and Wayne Winegarden
October 13, 2020
A new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute shows that counterfeit drugs put patients in harm’s way, hinder drug innovation, and lead to job losses. Proposals like drug importation or price controls, if implemented, would exacerbate the problem and result in more health and economic consequences.
|